India: Novartis Tries to Weaken Patent Laws That Protect Patients

September 19, 2011

Novartis is lobbying India's Supreme Court to undo a key safeguard in Indian patent law, which would have a devastating impact on access to affordable medicines across the developing world.

 

Tags: India, Access to Medicines, HIV/AIDS

Podcast » A Doctor Returns to Somaliland

Video » Trans-Pacific Trade Pact: Hands Off Our Medicines

Open Letters » MSF Open Letter: Words Must be Turned into Humanitarian Action for Syrians

Slideshow » Surviving Two Years of Treatment for Drug-Resistant TB in Kyrgyzstan

Special Report » Healing Iraqis: The Challenges of Providing Mental Health Care in Iraq

About Us | Field News | Contact Us | Donate | MSF Offices Worldwide

This site is maintained by the U.S. section of Doctors Without Borders/Médecins Sans Frontières (MSF), an international independent medical humanitarian organization that delivers emergency aid to people affected by armed conflict, epidemics, natural and man-made disasters, and exclusion from health care. © 2013 MSF All rights reserved.

Doctors Without Borders is approved by the Internal Revenue Service as a 501 (C) (3) tax-exempt organization, and all donations are tax deductible to the extent provided by law. Doctors Without Borders Federal Identification Number (EIN) is 13-3433452.

MSF-USA Association | Copyright Statement | Privacy Policy

333 7th Avenue, New York, NY 10001-5004. Phone: 212-679-6800